Quarterly Outlook
Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges
Althea Spinozzi
Head of Fixed Income Strategy
Access both platforms from your single Saxo account.
The Pfizer-Seagen takeover opens up a window of opportunity for long-dated U.S. Treasuries
Althea Spinozzi
Head of Fixed Income Strategy
Summary: The Pfizer-Seagen deal is likely to have caused the sudden rise of long-term U.S. Treasury yields above a critical resistance level. Thirty-year yields now look headed to 4% as they have broken bullish out of the symmetrical triangle-like pattern it has formed in the past couple of months. Today's 20-year U.S. Treasury auction, tomorrow's initial jobless claims, and the Philadelphia Fed business outlook might further contribute to their rise. Nevertheless, in the long term, the upside for long-term yields is limited, as they are poised to retrace while the economy decelerates.
While 2, 5, and 10-year U.S. Treasury yields are range bound, the 30-year Treasury yield has broken bullish out of the symmetrical triangle-like pattern it has formed over the past few months. They now look headed for resistance at around 4%. If breaking above the March peak at about 4.025%, there is potential for an October peak at about 4.40%. A move below 3.67% will demolish and reverse this bullish scenario (courtesy of Kim Cramer Larsson, Technical Analyst).
It’s important to note that long-term yields began to rise on Monday when rumors of a Pfizer-Seagen deal started to spread. By raising $31 billion, the Pfizer-Seagen deal became the fourth-largest deal in U.S. capital markets. For investors, it meant that bonds of a high-quality, non-cyclical company with a rating of A1/A+ would provide an alternative to U.S. Treasuries. That is particularly true on the long part of the yield curve, where yields remain compressed amid recessionary fears. The 40-year tranche was the highlight of the deal, pricing at 160bps over treasuries, down from 180bps IPT due to high demand. Consequently, investors sold Treasuries to make space in their portfolios to participate in the deal.
As Kim noted above, 30-year yields seem now headed towards 4%. Today's 20-year U.S. Treasury auction might help yields to rise further towards this level, as it remains one the least liked maturities across the yield curve. Tomorrow’s initial jobless claims and the Philadelphia Fed business outlook might also affect long-term yields.
Yet, the upside for long-term yields remains limited, as they are poised to retrace as the economy decelerates, consumer sentiment is weak, and credit tightening leads the economy into a recession.
What instruments should I use to get exposure to long-term U.S. Treasuries?
- 30YK3 is the Micro 30-year yield future contract expiring on May 31st, 2023. This future provides traders with an efficient way to trade U.S. Treasury yields. The contract will rise when Treasury yields increase and fall when they decline. Thus, there is no need to look at the inverse relationship between yield and price. CME also offers the same product for the following key tenors: 2-year (2YY), 5-year and 10-year Notes (10Y).
- 30-year U.S. Treasury Bond futures contract (ZB).
- 30YUSTBOND is the CFD on the U.S. Treasury Bond future contract.
- TLT is the iShares Barclays 20+ Year Treasury Bond Fund which gives exposure to the longer part of the yield curve.
Latest Market Insights
Quarterly Outlook
-
-
Quarterly Outlook
Equity Outlook: Will lower rates lift all boats in equities?
Peter Garnry
Chief Investment Strategist
After a period of historically high equity index concentration driven by the 'Magnificent Seven' sto... -
Quarterly Outlook
FX Outlook: USD in limbo amid political and policy jitters
Charu Chanana
Chief Investment Strategist
As we enter the final quarter of 2024, currency markets are set for heightened turbulence due to US ... -
Quarterly Outlook
Macro Outlook: The US rate cut cycle has begun
Peter Garnry
Chief Investment Strategist
The Fed started the US rate cut cycle in Q3 and in this macro outlook we will explore how the rate c... -
Quarterly Outlook
Commodity Outlook: Gold and silver continue to shine bright
Ole Hansen
Head of Commodity Strategy
-
Quarterly Outlook
FX: Risk-on currencies to surge against havens
Charu Chanana
Chief Investment Strategist
Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperfo... -
Quarterly Outlook
Equities: Are we blowing bubbles again
Peter Garnry
Chief Investment Strategist
Explore key trends and opportunities in European equities and electrification theme as market dynami... -
Quarterly Outlook
Macro: Sandcastle economics
Peter Garnry
Chief Investment Strategist
Explore the "two-lane economy," European equities, energy commodities, and the impact of US fiscal p... -
Quarterly Outlook
Bonds: What to do until inflation stabilises
Althea Spinozzi
Head of Fixed Income Strategy
Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain ... -
Quarterly Outlook
Commodities: Energy and grains in focus as metals pause
Ole Hansen
Head of Commodity Strategy
Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities i...
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)